Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Regulatory and methodologic challenges to tocolytic development.

T M Goodwin1

  • 1University of Southern California, Women's and Children's Hospital, Los Angeles, CA, USA. tgoodwin@usc.edu

BJOG : an International Journal of Obstetrics and Gynaecology
|January 9, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prenatal exposure to hyperemesis gravidarum linked to increased risk of psychological and behavioral disorders in adulthood.

Journal of developmental origins of health and disease·2014
Same author

No increased risk of psychological/behavioral disorders in siblings of women with hyperemesis gravidarum (HG) unless their mother had HG.

Journal of developmental origins of health and disease·2014
Same author

Health-related quality of life in women with nausea and vomiting of pregnancy: the importance of psychosocial context.

Journal of perinatology : official journal of the California Perinatal Association·2010
Same author

Effect of 17-alpha hydroxyprogesterone caproate on the production of tumor necrosis factor-alpha and the expression of cyclooxygenase-2 in lipopolysaccharide-treated gravid human myometrial explants.

Journal of perinatology : official journal of the California Perinatal Association·2010
Same author

The psychosocial burden of hyperemesis gravidarum.

Journal of perinatology : official journal of the California Perinatal Association·2007
Same author

Accessory scrotum: prenatal sonographic features.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2007
Same journal

Impact of a Structured Caesarean Reduction Strategy on Perinatal Outcomes: A Retrospective Ecological Time-Trend Study.

BJOG : an international journal of obstetrics and gynaecology·2026
Same journal

Long-Term Outcomes After Retropubic and Transobturator Sling Procedures: Reoperation for Recurrent Stress Urinary Incontinence.

BJOG : an international journal of obstetrics and gynaecology·2026
Same journal

First Trimester Screening for Preterm Preeclampsia in the United Kingdom: A Cost-Effectiveness Analysis.

BJOG : an international journal of obstetrics and gynaecology·2026
Same journal

Correction to "The Management of Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum (Green-Top Guideline No. 69)".

BJOG : an international journal of obstetrics and gynaecology·2026
Same journal

Large Language Models on European Guidelines for Cervical Cancer: Implications of Design and Clinical Applicability.

BJOG : an international journal of obstetrics and gynaecology·2026
Same journal

Internal Consistency of the Hadlock Estimated Fetal Weight Reference: Methodological Analysis.

BJOG : an international journal of obstetrics and gynaecology·2026
See all related articles

Developing tocolytic medications for preterm labor faces unique challenges due to evolving pathophysiology. This overview familiarizes obstetricians with these hurdles and proposes strategies for improved drug development.

Area of Science:

  • Obstetrics and Gynecology
  • Pharmacology
  • Maternal-Fetal Medicine

Background:

  • Drug development for tocolytic medications encounters general program challenges, primarily evolving pathophysiological understanding.
  • Unique impediments exist for developing medications for pregnancy-related conditions, especially tocolysis.

Purpose of the Study:

  • To familiarize obstetricians with current challenges in drug development.
  • To specifically focus on the problems encountered in tocolytic drug development for preterm labor.

Main Methods:

  • This is a brief overview and strategy presentation.
  • No specific experimental methods are detailed; it relies on existing knowledge and expert perspective.

Main Results:

Related Experiment Videos

  • Identifies significant challenges in the development pipeline for tocolytic agents.
  • Highlights the specific difficulties related to the unique physiological state of pregnancy.

Conclusions:

  • A strategy is presented to encourage drug development for preterm labor and general pregnancy-related issues.
  • Addressing these challenges is crucial for advancing treatment options in maternal medicine.